2020 consensus guideline for optimal approach to the diagnosis and treatment of HER2-positive breast cancer in Bosnia and Herzegovina. Biomol Biomed [Internet]. 2021 Apr. 1 [cited 2025 Apr. 16];21(2):120-35. Available from: https://www.bjbms.org/ojs/index.php/bjbms/article/view/4846